The biomarker Acetoacetate, measured in serum or plasma (S/P) is a key component in the evaluation of ketone body levels within the human body. Acetoacetate is one of the three primary ketone bodies, alongside beta-hydroxybutyrate and acetone, produced during the process of ketogenesis, which occurs primarily in the mitochondria of liver cells. This metabolic process is triggered under conditions where glucose availability is insufficient to meet the body's energy demands, such as during prolonged fasting, carbohydrate-restricted diets, or uncontrolled diabetes mellitus.
The measurement of acetoacetate is critical in diagnosing and monitoring conditions associated with altered metabolic states, such as diabetic ketoacidosis (DKA), starvation ketosis, and alcoholic ketoacidosis. In DKA, for example, the inability of cells to utilize glucose due to insufficient insulin leads to increased fatty acid oxidation and subsequent ketogenesis, resulting in elevated levels of acetoacetate and other ketone bodies. These compounds can accumulate to toxic levels, leading to metabolic acidosis, a potentially life-threatening condition characterized by decreased blood pH and altered electrolyte balance.
Elevated acetoacetate levels may necessitate interventions such as insulin therapy in the case of diabetic patients, nutritional support for those with starvation ketosis, or specific treatments addressing the underlying causes of increased ketogenesis. This marker, by reflecting the balance between carbohydrate availability and the body's energy requirements, provides critical insights into the patient's metabolic state, facilitating timely and appropriate medical response.
Acetoacetate, S/P
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.